Novavax completes process for WHO emergency use approval of COVID-19 vaccine

Reuters2021-11-05

Nov 4 (Reuters) - Vaccine developer Novavax Inc said on Thursday it has completed the submission process for emergency use listing of its COVID-19 vaccine candidate with the World Health Organization....

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

lee1234
2021-11-05
lee1234
Like
Ferocious
2021-11-05
Ferocious
Ok
- Ferocious:
  Ok
YunaTuna
2021-11-05
YunaTuna
Ok
NareshwG
2021-11-05
NareshwG
More vaccine means more protection to the people. This is good news 👍
- NareshwG:
  Yes.. 👍
- NareshwG:
  Ya.. 👍
- 滚股怪:
  High
- Prosperity88:
  yeh
- NareshwG:
  Thanks 😊

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2181970597?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2021-11-05 08:11","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2181970597","market":"us","top_or_hot":-1,"title":"Novavax completes process for WHO emergency use approval of COVID-19 vaccine","media":"Reuters","content":"<div>\n<p>Nov 4 (Reuters) - Vaccine developer Novavax Inc said on Thursday it has completed the submission process for emergency use listing of its COVID-19 vaccine candidate with the World Health Organization....</p>\n\n<a href=\"https://finance.yahoo.com/news/1-novavax-completes-process-emergency-203556983.html\">网页链接</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax completes process for WHO emergency use approval of COVID-19 vaccine</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax completes process for WHO emergency use approval of COVID-19 vaccine\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-05 08:11 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/1-novavax-completes-process-emergency-203556983.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Nov 4 (Reuters) - Vaccine developer Novavax Inc said on Thursday it has completed the submission process for emergency use listing of its COVID-19 vaccine candidate with the World Health Organization....</p>\n\n<a href=\"https://finance.yahoo.com/news/1-novavax-completes-process-emergency-203556983.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"NVAX","symbol_name":"诺瓦瓦克斯医药","start_time":0,"source_url":"https://finance.yahoo.com/news/1-novavax-completes-process-emergency-203556983.html","article_id":"2181970597","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2181970597","pubTimestamp":1636071071,"columns":[],"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"Nov 4 (Reuters) - Vaccine developer Novavax Inc said on Thursday it has completed the submission pro","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"translate_title":"诺瓦瓦克斯医药完成新冠肺炎疫苗世界卫生组织紧急使用批准程序","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NVAX":0.9},"content_text":"Nov 4 (Reuters) - Vaccine developer Novavax Inc said on Thursday it has completed the submission process for emergency use listing of its COVID-19 vaccine candidate with the World Health Organization.\nThe company submitted to the health agency all modules required for the evaluation of NVX-CoV2373, its protein-based COVID-19 vaccine, days after receiving its first emergency use authorization from Indonesia.\nThe company is also expecting regulators in countries including India and the Philippines to decide on its vaccine within weeks.\nA green light from the WHO would set the stage for Novavax to begin shipping doses to the COVAX program that supplies shots to low-income countries.\nNovavax is prepared to deliver its vaccine globally, Chief Executive Stanley Erck said in a statement. The company said it remains on track to file for U.S. approval by end of the year.\nThe Maryland-based vaccine developer reported a bigger net loss of $322.4 million, or $4.31 per share, for the third quarter, compared to $197.3 million a year earlier.\nRevenue rose to $178.8 million, mainly due to increased development activities relating to its COVID vaccine, including services performed under the U.S. government agreement and royalties from licensing pacts.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":846857943,"gmtCreate":1636074768830,"gmtModify":1636074769232,"author":{"id":"3579516715925048","authorId":"3579516715925048","name":"lee1234","avatar":"https://static.tigerbbs.com/c1a0ecabeae2d32250fce1eb7e612d3d","vip":1,"crmLevel":4,"crmLevelSwitch":0,"idStr":"3579516715925048","authorIdStr":"3579516715925048"},"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/846857943","repostId":2181970597,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":846882987,"gmtCreate":1636072986874,"gmtModify":1636072987144,"author":{"id":"3586857174644620","authorId":"3586857174644620","name":"Ferocious","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3586857174644620","authorIdStr":"3586857174644620"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/846882987","repostId":2181970597,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6459217,"gmtCreate":1636072993614,"gmtModify":1636072993641,"authorId":3586857174644620,"author":{"id":3586857174644620,"idStr":"3586857174644620","authorId":3586857174644620,"name":"Ferocious","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":846882987,"type":1,"supId":0,"prevId":0,"content":"Ok","text":"Ok","html":"Ok"}],"langContent":"CN"},{"id":846816675,"gmtCreate":1636072419367,"gmtModify":1636072419647,"author":{"id":"3581809523229784","authorId":"3581809523229784","name":"YunaTuna","avatar":"https://static.tigerbbs.com/6463ed1450c2454bfc57b76274b06418","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3581809523229784","authorIdStr":"3581809523229784"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/846816675","repostId":2181970597,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":846816326,"gmtCreate":1636072400561,"gmtModify":1636072413987,"author":{"id":"3572945845916163","authorId":"3572945845916163","name":"NareshwG","avatar":"https://static.tigerbbs.com/0d6dc06165c1a0cc4f1a8169ea48573d","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3572945845916163","authorIdStr":"3572945845916163"},"htmlText":"More vaccine means more protection to the people. This is good news 👍","listText":"More vaccine means more protection to the people. This is good news 👍","text":"More vaccine means more protection to the people. This is good news 👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":6,"repostSize":0,"link":"https://laohu8.com/post/846816326","repostId":2181970597,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6460495,"gmtCreate":1636076881154,"gmtModify":1636076881187,"authorId":3572945845916163,"author":{"id":3572945845916163,"idStr":"3572945845916163","authorId":3572945845916163,"name":"NareshwG","avatar":"https://static.tigerbbs.com/0d6dc06165c1a0cc4f1a8169ea48573d","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":846816326,"type":1,"supId":6459790,"prevId":0,"content":"Yes.. 👍","text":"Yes.. 👍","html":"Yes.. 👍"},{"id":6460489,"gmtCreate":1636076869412,"gmtModify":1636076869444,"authorId":3572945845916163,"author":{"id":3572945845916163,"idStr":"3572945845916163","authorId":3572945845916163,"name":"NareshwG","avatar":"https://static.tigerbbs.com/0d6dc06165c1a0cc4f1a8169ea48573d","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":846816326,"type":1,"supId":6459258,"prevId":0,"content":"Ya.. 👍","text":"Ya.. 👍","html":"Ya.. 👍"},{"id":6459790,"gmtCreate":1636074823337,"gmtModify":1636074823433,"authorId":4091089381144950,"author":{"id":4091089381144950,"idStr":"4091089381144950","authorId":4091089381144950,"name":"滚股怪","avatar":"https://static.tigerbbs.com/b67621b4133ca0db91bff9766152a448","vip":1,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":846816326,"type":1,"supId":0,"prevId":0,"content":"High","text":"High","html":"High"},{"id":6459258,"gmtCreate":1636073095646,"gmtModify":1636073095681,"authorId":3569644599778803,"author":{"id":3569644599778803,"idStr":"3569644599778803","authorId":3569644599778803,"name":"Prosperity88","avatar":"https://static.tigerbbs.com/673e75041219828ee5fce0d5b00ebbfe","vip":1,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":846816326,"type":1,"supId":0,"prevId":0,"content":"yeh","text":"yeh","html":"yeh"},{"id":6459037,"gmtCreate":1636072436233,"gmtModify":1636072436318,"authorId":3572945845916163,"author":{"id":3572945845916163,"idStr":"3572945845916163","authorId":3572945845916163,"name":"NareshwG","avatar":"https://static.tigerbbs.com/0d6dc06165c1a0cc4f1a8169ea48573d","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":846816326,"type":1,"supId":6459028,"prevId":0,"content":"Thanks 😊","text":"Thanks 😊","html":"Thanks 😊"}],"langContent":"CN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":97,"commentSize":4,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2181970597"}